AKRO
Price
$36.71
Change
-$3.28 (-8.20%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
2.92B
45 days until earnings call
ZIVO
Price
$15.75
Change
-$1.35 (-7.89%)
Updated
Apr 2 closing price
Capitalization
59.28M
Ad is loading...

AKRO vs ZIVO

Header iconAKRO vs ZIVO Comparison
Open Charts AKRO vs ZIVOBanner chart's image
Akero Therapeutics
Price$36.71
Change-$3.28 (-8.20%)
Volume$34.17K
Capitalization2.92B
Zivo Bioscience
Price$15.75
Change-$1.35 (-7.89%)
Volume$656
Capitalization59.28M
AKRO vs ZIVO Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. ZIVO commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Hold and ZIVO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (AKRO: $39.99 vs. ZIVO: $15.75)
Brand notoriety: AKRO and ZIVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 83% vs. ZIVO: 84%
Market capitalization -- AKRO: $2.92B vs. ZIVO: $59.21M
AKRO [@Biotechnology] is valued at $2.92B. ZIVO’s [@Biotechnology] market capitalization is $59.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileZIVO’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • ZIVO’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than ZIVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 4 TA indicator(s) are bullish.

  • AKRO’s TA Score: 4 bullish, 5 bearish.

Price Growth

AKRO (@Biotechnology) experienced а -8.24% price change this week, while ZIVO (@Biotechnology) price change was -7.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

AKRO is expected to report earnings on May 20, 2025.

ZIVO is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($2.92B) has a higher market cap than ZIVO($59.3M). AKRO YTD gains are higher at: 43.746 vs. ZIVO (-26.744). ZIVO has higher annual earnings (EBITDA): -13.66M vs. AKRO (-247.37M). AKRO has more cash in the bank: 743M vs. ZIVO (159K). ZIVO has less debt than AKRO: ZIVO (377K) vs AKRO (36.5M). ZIVO has higher revenues than AKRO: ZIVO (79K) vs AKRO (0).
AKROZIVOAKRO / ZIVO
Capitalization2.92B59.3M4,929%
EBITDA-247.37M-13.66M1,811%
Gain YTD43.746-26.744-164%
P/E RatioN/AN/A-
Revenue079K-
Total Cash743M159K467,296%
Total Debt36.5M377K9,682%
FUNDAMENTALS RATINGS
ZIVO: Fundamental Ratings
ZIVO
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKRO
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 24 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBLG0.860.02
+1.91%
Bone Biologics Corp
SLS1.100.01
+0.92%
SELLAS Life Sciences Group
NIO3.74-0.06
-1.58%
NIO Inc.
RAMP25.23-1.38
-5.19%
LiveRamp Holdings
CEVA22.55-3.66
-13.96%
CEVA

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
-4.67%
ETNB - AKRO
57%
Loosely correlated
-4.59%
SLS - AKRO
39%
Loosely correlated
+0.92%
VTYX - AKRO
38%
Loosely correlated
-5.66%
MDGL - AKRO
37%
Loosely correlated
-2.24%
TRDA - AKRO
37%
Loosely correlated
-8.86%
More

ZIVO and

Correlation & Price change

A.I.dvisor tells us that ZIVO and APLM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZIVO and APLM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZIVO
1D Price
Change %
ZIVO100%
N/A
APLM - ZIVO
28%
Poorly correlated
-16.13%
LGVN - ZIVO
24%
Poorly correlated
-7.05%
MDXXF - ZIVO
24%
Poorly correlated
+3.66%
AKRO - ZIVO
23%
Poorly correlated
-4.67%
ATOS - ZIVO
23%
Poorly correlated
-6.56%
More